American Vanguard Corp. (NYSE:AVD) has been getting punished recently because of its poor showing in the last quarter, where revenue was down, earnings missed, and operating expenses soared.
This isn't too worrisome, as it's the nature of a company serving the agriculture segment to sometimes experience these types of results because of weather and farmers cutting back on spending on certain crops.
Fortunately, it looks like the second half of 2013 will be much better, with sales of Metam, Bidrin, Dibrom, Vapam, and Folex expected to rise because of various conditions conducive to those products, including weather and pests.
Over the longer term its Impact herbicide and equity investment in life sciences company TyraTech, Inc. could drive sales...
|FREE||SA PRO MEMBERS|
|IDEA GENERATOR||X||Exclusive access to 10 PRO ideas every day|
|INVESTING IDEAS LIBRARY||X||Exclusive access to PRO library of more than 15,000 ideas|
|SECTOR EXPERT NETWORK||X||Exclusive access to all sector experts for direct consultation|
|PERFORMANCE TRACKING||X||Track performance of all PRO stock ideas|
|PROFESSIONAL TOOLS||X||Professional Idea Filters to zero-in based on industry, market cap and more|